Stay updated with the latest drugs-controller-general-of-india news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on drugs-controller-general-of-india topics.
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. Also Read | Indian Railways Carries 1,670 MT Freight, Runs 25,000 Trains Daily in Financial Year 20 ...Read More >
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. According to the Official sources, the IPC has started the regular monitoring of adverse events of ...Read More >
NEW DELHI: With prices of GLP-1 drugs crashing and their generic versions flooding the market, govt has cracked down on their misuse, inspecting 49 businesses and issuing notices while also flagging risks of unsupervised consumption in a detailed advisory.To ensure ethical pharmaceutical practices, Drug Controller General of India has intensified surveillance of unauthorised sale and promotion of the drugs. In India, GLP-1 medicines can be prescribed only by endocrinologists, internal medicine s ...Read More >
NEW DELHI: Amid continued violations and the widespread misuse and easy availability of weight loss drugs in the market, the Centre on Wednesday warned that those who break the rules "will face licence cancellation, fines and legal action." In a detailed note on GLP 1 drugs, their use, risks and regulation, the Centre said multiple variants of weight loss drugs have recently been introduced in the Indian market, raising concerns over their on demand availability through retail pharmacies, onlin ...Read More >
NEW DELHI: India's drug regulator has sought strict compliance with revised Schedule M. It has asked state drug regulators to carry out inspections of pharma manufacturing units which have applied for extension of Schedule M to verify their compliance with the requirements, in a bid to ensure quality of pharma products by mandating Good Manufacturing Practices (GMP). "In case any manufacturing unit is found non-complying to the requirements of revised Schedule M during inspections, strict actio ...Read More >
After contaminated cough syrups made headlines linked to child deaths in Madhya Pradesh and Rajasthan, India's drug regulator has launched a digital monitoring system so that officials can oversee production, movement and quality of high-risk ingredients used in making these formulations. The move comes after several reports of diethylene glycol (DEG) contamination in cough syrups, which raised serious safety concerns and prompted nationwide scrutiny of pharmaceutical manufacturing practices. ...Read More >
Amid growing demand for stricter compliance with safety and quality control norms for medical products, the Centre is framing a law to strengthen the legal framework for drug quality testing and market surveillance, along with regulation of medical devices and cosmetics. One of the major reasons behind the drafting of the law is the repeated complaints and concerns flagged by health regulators across the globe, including the WHO, over serious quality lapses by Indian drug manufacturers. The dr ...Read More >
New Delhi, Oct 9 (PTI) Central drug regulator CDSCO has informed the World Health Organisation (WHO) that three cough syrups -- Coldrif, RespifreshTR and ReLife -- have been recalled and manufacturers have been ordered to stop their production. The CDSCO on Wednesday informed the global health agency that none of the products were exported from India, official sources said. The WHO had sought to know from Indian authorities whether the cough syrup linked to children deaths in the country was e ...Read More >
After the death of at least 20 children in Madhya Pradesh due to the consumption of contaminated cough syrup, the Central Drugs Standard Control Organisation (CDSCO) on Wednesday issued a strict advisory for drug controllers of all states and Union Territories and instructed them to ensure every batch of raw material and finished formulation is properly tested before use or sale. The advisory, dated October 7, 2025, was sent by Dr Rajeev Singh Raghuvanshi, Drug Controller General of India (DCGI ...Read More >
The Union health ministry addressed cough syrup quality. A meeting reviewed drug norm compliance. This followed child deaths linked to syrups in Chhindwara and Rajasthan. States received advice on cough syrup use for children. One cough syrup, Coldrif, contained DEG beyond limits. Action occurred against the manufacturer. Inspections began across 19 units. Officials urged adherence to manufacturing practices. Amid concerns over the quality of cough syrups, the Union health ministry on Sunday un ...Read More >
Bhopal, Oct 6 (PTI) The Madhya Pradesh government on Monday suspended two drug inspectors and a Deputy Director of the food and drug administration amid the probe into the death of 14 children from Chhindwara due to suspected renal failure, linked to the consumption of a "toxic" cough syrup. Chief Minister Mohan Yadav also transferred the state's Drug Controller, Dinesh Maurya, after reviewing the situation in a high-level meeting. The suspended drug inspectors are identified as Gaurav Sharma ...Read More >
New Delhi [India], August 22 (ANI): India drug regulator has alerted on the theft of multiple drug products of Novo Nordisk during transit. According to the notice issued by the Drugs Controller General of India (DCGI), Dr Rajeev Raghuvanshi, Mis Novo Nordisk has informed about a theft of its products, as mentioned below, during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata). The DCGI has also mentioned in the notice that the quality of the injectables is re ...Read More >
The District Magistrate of South Delhi has mandated CCTV installations in pharmacies to prevent illegal drug sales, focusing on Schedule H, H1, and X drugs. The All-India Organisation of Chemists and Druggists raises concerns over unregulated online pharmacies, urging swift action against illegal sales threatening public health. The District Magistrate of South Delhi has announced a new regulation mandating the installation of CCTV cameras in all pharmacies across the national capital. This ini ...Read More >
BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an investigation into alleged unethical clinical trials at Bengaluru-based HCG Hospital, a well-known cancer care hospital chain. The department acted after Justice P Krishna Bhat, former chairperson of the Institutional Ethics Committee (IEC) at HCG, raised serious concerns and resigned earlier this year. His resignation followed complaints about how clinical trials were bein ...Read More >
Kolkata: The CBI on Wednesday filed a supplementary charge sheet in the 2021 murder case of BJP worker Abhijit Sarkar, who was killed during post-election violence in Kankurgachhi. The charge sheet names Beleghata MLA Paresh Pal, Kolkata Municipal Corporation councillors Swapan Samaddar and Papiya Ghosh, along with 15 others.In the FIR, Sarkar's mother Madhabi said that on May 2, 2021, eight persons barged into their house at Narkeldanga around 3 pm and started enquiring about her son. The miscr ...Read More >
Bengaluru: The Central Drugs Standards Control Organisation (CDCSO) has set up a team to inspect the ethics committee of HCG Hospital, Bengaluru, amid concerns over conduct of clinical trials at the private facility. The inspection will take place Thursday and Friday.The decision follows a letter from K Srinivas, commissioner of food safety and drug administration, to CDCSO, pointing to potential violations in trial conduct that could affect patient safety, regulatory compliance and institutiona ...Read More >
New Delhi, Jul 2 (PTI) The Delhi High Court on Wednesday asked the Drug Controller General of India to consult experts and relevant stakeholders in deciding a plea over drug combinations sold in the market for weight loss treatment. A bench of Chief Justice D K Upadhyaya and Justice Tushar Rao Gedela asked the petitioner to give a representation to the DGCI, which was asked to decide the matter within three months. Also Read | 'Janaki' Title Row: Malayalam Film Industry Holds Protest in Front ...Read More >
New Delhi, Jul 2 (PTI) The Delhi High Court on Wednesday asked the Drug Controller General of India to consult experts and relevant stakeholders in deciding a plea over drug combinations sold in the market for weight loss treatment. A bench of Chief Justice D K Upadhyaya and Justice Tushar Rao Gedela asked the petitioner to give a representation to the DGCI, which was asked to decide the matter within three months. A plea filed by Jitendra Chouksey said licenses issued for the use and sale of ...Read More >
Bengaluru, Jul 2 (PTI) Bengaluru-headquartered Health Care Global Enterprises Limited (HCG) on Wednesday denied allegations of unfair trials at its facility, claiming that it is successfully conducting a significant number of clinical trials with utmost transparency and prioritising patient safety, approved by its Ethics Committee. The development came after Justice P Krishna Bhat (Retd), former chairperson of the Institutional ethics committee of HCG, levelled allegations following which the K ...Read More >
New Delhi: Drugmaker Wockhardt said its novel antibiotic Zaynich has an addressable market opportunity of $7 billion in the US and Europe. The company said it has completed a pre-NDA (non-disclosure agreement) meeting with the US Food and Drug Administration (USFDA) in May 2025. Filing to the USFDA is slated in the second quarter of the current fiscal with potential launch in FY2026-27, Wockhardt Ltd said in a regulatory filing. The company plans for regulatory approval for the product in Europ ...Read More >
NEW DELHI: India plans to roll out the HPV vaccine in the national immunization programme for school girls to protect them from cervical cancer "in a few months" time, top health ministry officials said Tuesday. "The HPV vaccine will be rolled out in a few months but we will have to wait for the TB vaccine," said Union Health Secretary Punya Salila Srivastava at a press conference held by Union Health Minister J P Nadda. Without giving any more details, she said, the ministry is strategizing t ...Read More >
Bengaluru, Dec 3 (PTI) The Karnataka government on Tuesday requested the Drugs Controller General of India (DCGI) to investigate and take necessary action against a West Bengal-based manufacturer, amid concerns that recent maternal deaths in Ballari district, could be linked to substandard Ringer Lactate solution supplied by the company. In a letter, Karnataka Health Principal Secretary Harsh Gupta, drew the attention of the DCGI to the supply of several batches of "Compound Sodium Lactate I P ...Read More >
Advocacy group urges swift implementation of procurement process to benefit patients Cure SMA Foundation of India, a parent-led patient advocacy organisation for Spinal Muscular Atrophy (SMA), has commended recent steps taken by the Government of India, the judiciary, and healthcare stakeholders to address rare diseases. The Ministry of Health and Family Welfare and the Delhi High Court have allocated over Rs 900 crore for rare disease treatment, including SMA, marking a milestone for the com ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.